Assessing Clinical Trial Experiences of Patients With Osteosarcoma

An Observational Study Investigating The Experiences of Patients In Osteosarcoma Clinical Trials

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05535283

Enrollment

500

Registered

2022-09-10

Start date

2024-10-31

Completion date

2026-10-31

Last updated

2024-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteosarcoma

Keywords

osteosarcoma

Brief summary

Clinical study participation has historically been heavily biased toward specific demographics. Several people will be invited to enroll in this study so that it may collect a variety of data about osteosarcoma clinical trial experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal. People with osteosarcoma who are invited to take part in medical research will benefit from the analysis of the data.

Interventions

None listed

Study design

Observational model

CASE_CROSSOVER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient has been diagnosed with osteosarcoma * Patient has self-identified as planning to enroll in an interventional clinical trial * Patient is a minimum of 18 years or older

Exclusion criteria

* ECOG score of 4 * Patient is pregnant * Inability to perform regular electronic reporting * Patient does not understand, sign, and return consent form

Design outcomes

Primary

Measure	Time frame
Number of patients who decide to enroll in an osteosarcoma clinical trial	3 months
Rate of patients who remain in osteosarcoma clinical trial to trial completion	12 months

Contacts

Primary ContactMichael B Gill

bask@withpower.com4159004227

Outcome results